Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 24, 2018

View Archived Issues

Gilteritinib granted orphan designation in Europe for treatment of AML

Tmunity announces closing of series A financing

Inhibitors of ATP1A4 may be novel agents for male contraception

Swissmedic accepts filing for edaravone as treatment for ALS

Skyhawk Therapeutics announces launch with USD 8 million in seed funding

Domainex wins award to develop screening method for GPCRs

Astellas completes Mitobridge acquisition

LifeArc enters partnership to identify new drug targets with machine-learning, bioinformatics

New mu-opioid receptor/CACNA2D1 ligands identified at Laboratorios del Dr. Esteve

Roche discovers novel HBsAg and HBV DNA production inhibitors

Glaceum describes novel glucose-lowering agents

FDA approves IND for Traumakine for ARDS

Evofem initiates phase IIb/III study of Amphora to prevent chlamydia and gonorrhea infections

University of California, Oakland patents HPV16 E5 gene-specific siRNA

Novel HPV vaccines synthesized at Deutsches Krebsforschungszentrum

Margetuximab awarded fast track designation for metastatic HER-positive breast cancer

Tie1 targeting shown to reduce tumor metastasis and growth

CARB-X seeks new accelerator organizations

NIH launches Somatic Cell Genome Editing program

Inclisiran receives FDA orphan designation for homozygous familial hypercholesterolemia

BioMarck Pharmaceuticals starts phase II trial of BIO-11006

Qiagen's ipsogen JAK2 assay cleared by FDA

EMA committee communicates negative trend vote to Puma for neratinib MAA

FDA clears BioAtla's IND for BA-3011